quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 26, 2026

Got $10,000? Lockheed Martin Could Be a Defense Powerhouse That Outlasts Trump's Term

View original at nasdaq.com
“Net profit margin declined 110 basis points to 8.3%.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Stock Advisor's total average return is 983%, versus 200% for the S&P 500.

    60% confidence
  • Lockheed Martin predicts it will grow sales only 3% to 6% in the first year of its production ramp-up.

    60% confidence
  • Lockheed Martin signed several framework agreements to accelerate and scale munitions production, including advanced Patriot Missile, THAAD, and PrSM.

    60% confidence
  • Lockheed Martin was not among the 10 best stocks for investors to buy now, per the Motley Fool Stock Advisor analyst team.

    60% confidence
  • A $1,000 investment in Nvidia at the time of Motley Fool's April 15, 2005 recommendation would have grown to $1,276,807 as of April 25, 2026.

    60% confidence
  • A $1,000 investment in Netflix at the time of Motley Fool's December 17, 2004 recommendation would have grown to $498,522 as of April 25, 2026.

    60% confidence
  • Trump called the F-35 Lightning II 'not very good' during his first term and complained about Lockheed Martin's high prices.

    60% confidence
  • Annual production rates for at least some of Lockheed Martin's missiles are expected to grow three- or even fourfold under the new multiyear agreements.

    60% confidence
  • Lockheed Martin forecasts full-year 2026 earnings of $29.35 to $30.25 per share, representing approximately 37% growth at the midpoint versus 2025 profits.

    60% confidence
  • Lockheed Martin pioneered a number of commercially inspired, long-term business arrangements with US government leadership during Q1 2026.

    60% confidence
  • Trump vowed to cut the US military budget in half.

    60% confidence

Data points we hold from this source

Lockheed Martin Corporation · capex growth12 percent
Lockheed Martin Corporation · net margin8.3 percent
Lockheed Martin Corporation · revenue analyst consensus18.3 USD
Lockheed Martin Corporation · margin11.7 percent
Lockheed Martin Corporation · capex511 USD
Lockheed Martin Corporation · eps analyst consensus6.74 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Got $10,000? Lockheed Martin Could Be a Defense Powerhouse That Outlasts Trump's Term — Source | Via News | pt.VIA.NEWS